AEGLE THERAPEUTICS
Aegle Therapeutics is a privately-held biotechnology company developing a first in class therapy using extracellular vesicles, including exosomes, secreted by allogeneic bone marrow-derived mesenchymal stem cells. Aegle's platform technology is initially being developed to treat dystrophic epidermolysis bullosa, a rare pediatric skin blistering disorder. Aegle's IND for DEB has been cleared by the FDA and the company expects to enter the clinic by the 2H of 2020. Its proprietary platform isolati... on technology is cell-free and has the potential to demonstrate a safer, lower-cost means of harnessing the regenerative healing power of stem cells without using the cells. Aegle believes its EV therapy has the potential for functional regeneration and organization of complex tissue structures that can enhance healing, reduce scarring, minimize contraction, and improve overall cosmesis. The company was founded in 2013 and is based in Miami, Florida.
AEGLE THERAPEUTICS
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2013-01-01
Address:
Miami, Florida, United States
Country:
United States
Website Url:
http://www.aegletherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
13.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Apache Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Unified Layer
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Advisors List
Current Employees Featured
Founder
Investors List
DeepWork Capital
DeepWork Capital investment in Convertible Note - Aegle Therapeutics
DeepWork Capital
DeepWork Capital investment in Series A - Aegle Therapeutics
Ocean Azul Partners
Ocean Azul Partners investment in Series A - Aegle Therapeutics
Tellus BioVentures
Tellus BioVentures investment in Series A - Aegle Therapeutics
New World Angels
New World Angels investment in Series A - Aegle Therapeutics
DEFTA Partners
DEFTA Partners investment in Series A - Aegle Therapeutics
New World Angels
New World Angels investment in Series A - Aegle Therapeutics
Ocean Azul Partners
Ocean Azul Partners investment in Series A - Aegle Therapeutics
DeepWork Capital
DeepWork Capital investment in Series A - Aegle Therapeutics
Tellus Partners
Tellus Partners investment in Series A - Aegle Therapeutics
Official Site Inspections
http://www.aegletherapeutics.com Semrush global rank: 9.95 M Semrush visits lastest month: 76
- Host name: ec2-3-220-221-84.compute-1.amazonaws.com
- IP address: 3.220.221.84
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
